eISSN: 2081-2833
ISSN: 2081-0016
Medycyna Paliatywna/Palliative Medicine
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
2/2015
vol. 7
 
Share:
Share:
more
 
 
abstract:
Review paper

Radionuclide therapy of bone metastases in view of α-emitters appearance

Olgierd Chrabański

Medycyna Paliatywna 2015; 7(2): 101–105
Online publish date: 2015/08/13
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Constantly increasing number of cancer patients increases at the same time a group of patients suffering from bone metastases. These patients are usually a relatively long term survival patients who require specialized care and effective pain relief. The use of radioactive isotopes such as strontium isotope 89 or samarium isotopes 153, in the treatment, can help to relieve pain of patients with metastases in the skeletal system. Recently, it is also possible to provide an alpha emitter of radium isotope 223, which extends the life of patients with prostate cancer which is hormone refractory in treatment. Common misconception is that treatment of pain with the use of radionuclides is ineffective and difficult to access. In addition, the above procedures often considered as highly specialised are implemented too late.
keywords:

neoplasm metastasis, bones, strontium radioisotopes, radium

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.